Allergic rhinitis. Outcomes of immunotherapy on symptom control.
Recent scientific studies have demonstrated the efficacy of various forms of immunotherapy for the treatment of allergic diseases. Traditional subcutaneous immunotherapy, sublingual, oral, and intranasal immunotherapy have been shown to significantly reduce symptoms and favorably modulate the immune response. Outcome studies that use patient response data from standardized surveys represent the next challenge to all practicing allergists.
Cook
P R
PR
Department of Surgery, University of Missouri School of Medicine, Columbia, USA.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage / Q000627:therapeutic use; D000906:Antibodies / Q000032:analysis; D003888:Desensitization, Immunologic / Q000379:methods*; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007279:Injections, Subcutaneous; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D006255:Rhinitis, Allergic, Seasonal / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D012449:Safety; D012882:Skin Tests; D016896:Treatment Outcome
D000485:Allergens; D000906:Antibodies; D007073:Immunoglobulin E